NeuroMetrix wins FDA clearance to market its Sensus neurostimulation device for pain management during sleep.

NeuroMetrix’s (NSDQ:NURO) Sensus wearable pain management device can now be paired with pajamas thanks to the FDA’s clearance of the device for use during sleep.

The FDA typically requires warning labels for transcutaneous electrical nerve stimulators like Sensus because of their tendency to dislodge during sleep, which may pose an electrical hazard. NeuroMetrix says its Sensus system features a risk-assessment algorithm that mitigates that risk.